002198 Stock Overview
Guangdong Jiaying Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Guangdong Jiaying Pharmaceutical Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.74 |
| 52 Week High | CN¥9.30 |
| 52 Week Low | CN¥4.67 |
| Beta | 0.69 |
| 1 Month Change | -12.92% |
| 3 Month Change | 5.64% |
| 1 Year Change | -5.73% |
| 3 Year Change | -12.69% |
| 5 Year Change | 23.67% |
| Change since IPO | 53.18% |
Recent News & Updates
Revenues Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) After Shares Rise 31%
Nov 20
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Jiaying Pharmaceutical (SZSE:002198)
Nov 06Recent updates
Revenues Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) After Shares Rise 31%
Nov 20Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Jiaying Pharmaceutical (SZSE:002198)
Nov 06Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 03There May Be Reason For Hope In Guangdong Jiaying Pharmaceutical's (SZSE:002198) Disappointing Earnings
May 03Earnings Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198)
Mar 12Shareholder Returns
| 002198 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -8.3% | -1.7% | -1.0% |
| 1Y | -5.7% | -4.3% | 10.8% |
Return vs Industry: 002198 underperformed the CN Pharmaceuticals industry which returned -4.3% over the past year.
Return vs Market: 002198 underperformed the CN Market which returned 10.8% over the past year.
Price Volatility
| 002198 volatility | |
|---|---|
| 002198 Average Weekly Movement | 8.2% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 002198 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002198's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 700 | n/a | www.gdjyzy.com.cn |
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patient medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also offers provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufenghuoluo tablets, Tiaomenghuoxue tablets, and etc. Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd Fundamentals Summary
| 002198 fundamental statistics | |
|---|---|
| Market cap | CN¥3.41b |
| Earnings (TTM) | CN¥12.29m |
| Revenue (TTM) | CN¥415.61m |
278.4x
P/E Ratio8.2x
P/S RatioIs 002198 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002198 income statement (TTM) | |
|---|---|
| Revenue | CN¥415.61m |
| Cost of Revenue | CN¥176.63m |
| Gross Profit | CN¥238.97m |
| Other Expenses | CN¥226.69m |
| Earnings | CN¥12.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 57.50% |
| Net Profit Margin | 2.96% |
| Debt/Equity Ratio | 0% |
How did 002198 perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield206%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 15:16 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Jiaying Pharmaceutical Co., Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fenghua Wang | Shenwan Hongyuan Securities |